Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study.
Henrik JespersenRoger Olofsson BaggeGustav UllenhagAna CarneiroHildur HelgadottirIngrid LjuslinderMax LevinCharlotta All-ErikssonBengt AnderssonUlrika StiernerLisa M NilssonJonas A NilssonLars NyPublished in: BMC cancer (2019)
ClinicalTrials.gov registration number: NCT02697630 . (Registered 3 March 2016). EudraCT registration number: 2016-002114-50.